pca-lip-peptide-therapy The mog peptide 35-55 mouse rat acetate is a critical reagent in neuroscience research, specifically for modeling experimental autoimmune encephalomyelitis (EAE), a condition that mimics aspects of multiple sclerosis in humans.Myelin Oligodendrocyte Glycoprotein Peptide (35-55) ... This particular peptide fragment, derived from Myelin Oligodendrocyte Glycoprotein (MOG), plays a key role in inducing EAE in laboratory animals, primarily rodents like mice and rats. Researchers utilize this peptide to study the mechanisms of demyelination and neuroinflammation, seeking to understand the immune system's attack on the central nervous system.
Myelin Oligodendrocyte Glycoprotein (MOG) is a protein found in the myelin sheath, which insulates nerve fibers in the central nervous system. The MOG peptide 35-55 represents a specific sequence within this larger protein that is known to be highly immunogenic. When introduced into susceptible animal models, this peptide fragment triggers an autoimmune response, leading to the development of EAE. The acetate form is common for its stability and solubility, facilitating its use in experimental settings.
EAE is the most widely used animal model for studying the pathogenesis and potential treatments for multiple sclerosis (MS). The induction of EAE using mog peptide 35-55 mouse rat acetate allows researchers to:
* Investigate Disease Mechanisms: By studying the immune cells and inflammatory mediators that target the myelin sheath after MOG peptide administration, scientists gain insights into the cellular and molecular processes underlying demyelinating diseases.
* Test Therapeutic Interventions: The model provides a platform for evaluating the efficacy of novel drugs and therapies aimed at preventing or reversing the damage caused by autoimmune attacks on the CNS. This includes testing immunomodulatory agents, neuroprotective compounds, and regenerative strategies.Galectin-1 is essential for the induction of MOG 35–55 - ...
* Study T Cell Responses: The MOG peptide is a potent T cell antigenMOG(35-55)acetate；MOG(35-55) (rat,mouse). Description.MOG（35-55) is a glycoprotein from human myelin oligodendrocyte (MOG) truncatedpeptides.. Research using this peptide helps to elucidate the role of specific T helper cell subsets (like Th1 and Th17) and regulatory T cells in the development and resolution of autoimmune inflammation in the CNS.
While the mog peptide 35-55 mouse rat acetate is frequently used, it's important to note that variations may exist. The peptide sequence itself is conserved across species, but the immunogenic epitopes can differ slightly. Therefore, researchers often specify whether they are using a peptide derived from mouse or rat MOG, as subtle differences in antigen presentation or immune recognition can influence disease induction and severity. The term "acetate" refers to the counterion of the peptide, which is a common and stable form for peptide reagents. Other forms, like trifluoroacetate salts, may also be encountered, each with slightly different propertiesMOG peptide (35-55) , mouse, rat acetate - 1 mg.
The primary application of mog peptide 35-55 mouse rat acetate is in immunological and neurological research. It is typically supplied as a purified peptide for in vitro and in vivo studies. When using this reagent, researchers must adhere to strict laboratory protocols, including proper handling, storage, and administration to achieve reproducible results. The concentration, purity, and formulation of the peptide are critical factors that can affect the outcome of EAE induction.TargetmolMouse,rat MOG peptide(35-55)acetate, part of myelin glycoprotein, for immune disease research. Furthermore, understanding the specific genetic background of the mouse or rat strain used is crucial, as susceptibility to EAE can vary significantly between strains.Myelin Oligodendrocyte Glycoprotein35-55,mouse,rat(MOG 35-55) is a minor ...PeptideContent (by %N), ≥80%. Single Impurity (by HPLC), ≤1.0%. Assay ...
In conclusion, the mog peptide 35-55 mouse rat acetate is an indispensable tool for advancing our understanding of autoimmune demyelinating diseases. Its ability to reliably induce EAE in rodent models provides a crucial avenue for exploring disease pathogenesis and developing effective therapeutic strategies for conditions like multiple sclerosis.
Join the newsletter to receive news, updates, new products and freebies in your inbox.